-- Swiss Stocks Advance as U.S. Confidence Report Beats
-- B y   T o m   S t o u k a s
-- 2013-05-28T15:43:59Z
-- http://www.bloomberg.com/news/2013-05-28/swiss-stocks-advance-before-u-s-economic-data.html
Swiss stocks  advanced, extending the
benchmark index’s ninth monthly gain, as consumer confidence and
 house prices  in the world’s largest economy increased more than
forecast.  Logitech International SA (LOGN)  climbed after  Credit Suisse Group
AG (CSGN)  upgraded its recommendation for the shares. Basilea
Pharmaceutica AG jumped to its highest price since June 2011
after saying its isavuconazole treatment has won orphan-drug
status in the U.S.  The  Swiss Market Index (SMI)  rose 0.7 percent to 8,221.22 at the
close of trading in Zurich, bringing the monthly gain for the
index to 4 percent. The benchmark gauge has surged 29 percent
since August 2012, for its longest monthly rally since July
1997, as central banks around the world continued their asset-buying programs. The Swiss Performance Index gained 0.8 percent
today.  “Global investors have bought the dip after a volatile
recent week and are positive coming in to a shortened week in
the U.S.,” Daniel Weston, a portfolio manager at Aimed Capital
Management LLC in Munich, wrote in an e-mail.  In the U.S.,  consumer confidence  rose this month to the
highest level since February 2008. The Conference Board’s index
rose to 76.2 from a revised 69 in April, data from the New York-based private research group showed today. The median forecast
called for an increase to 71.2.  Separate data showed the S&P/Case-Shiller index of property
values increased 10.9 percent in March from the same month last
year, the biggest 12-month gain since April 2006, after
advancing 9.4 percent in February. The median projection of 30
economists surveyed by Bloomberg called for a 10.2 percent
advance.  Logitech Upgrade  Logitech, the world’s largest maker of computer mice,
gained 0.8 percent to 6.30 Swiss francs, paring earlier gains of
as much as 2.7 percent. The stock was upgraded to neutral from
underperform at Credit Suisse, which cited an improving short-term outlook and a wider product portfolio.  Basilea (BSLN)  jumped 6.8 percent to 72.40 francs after saying
that the U.S. Food and Drugs Administration granted orphan-drug
status to its isavuconazole treatment for invasive
aspergillosis. The U.S. offers several benefits including a
seven-year exclusivity for drugs addressing very small markets.  Cie. Financiere Richemont, the owner of the Cartier brand,
advanced 3 percent to 91.65 francs. Swiss watch exports rose 5.7
percent in April from a year ago, a report showed today.  UBS AG (UBSN)  and Credit Suisse,  Switzerland ’s largest lenders,
added 1.5 percent to 17.47 francs and 2.2 percent to 28.64
francs, respectively. A gauge of European bank shares was the
 best performer  among the 19 industry groups on the Stoxx Europe
600 Index.  Adecco SA (ADEN) , the world’s largest supplier of temporary
workers, rose 2.8 percent to 56.80 francs. Deutsche Bank AG
listed Adecco as one of its preferred stocks among companies
whose revenues are closely linked to economic performance.
Deutsche Bank has a buy rating on the shares.  Orascom Development Holding AG (ODHN)  slid 1.4 percent to 10.30
francs. The hotel developer reported a first-quarter loss of
19.1 million francs ($19.7 million) compared with a loss of 4
million francs during the same period last year.  To contact the reporter on this story:
Tom Stoukas in Athens at 
 astoukas@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  